Specialty and Natural Foods Sector Outlook — September 2026
A sector view of Specialty and Natural Foods for owners, boards and management teams. It covers how packaged foods, ingredient supply and adjacent models are priced on EV/EBITDA (CY2027E), where growth and margin diverge from valuation, and what recent precedent transactions reveal about deal terms.
For information only. Not an appraisal or a fairness opinion.
What moved since: Specialty and Natural Foods M&A update, 14–28 September 2026
Key figures
- Sector median EV/EBITDA
- 6.2x
- CY2027E, 7 of 12 companies rated
- Premium end of rated set
- 11.3x
- EV/EBITDA (CY2027E)
- Discount end of rated set
- 2.9x
- EV/EBITDA (CY2027E)
- Packaged foods share
- 67%
- of the peer set
Read the report
1 / 21 · CONSUMER STAPLES › FOOD, BEVERAGE AND TOBACCO › SPECIALTY AND NATURAL FOODS
Executive summary
Specialty and Natural Foods prices in a wide band: rated names range from 2.9x to 11.3x EV/EBITDA on CY2027E consensus, against a sector median of 6.2x. Faster forecast growth does not line up with higher pricing, and above-median margin does not secure premium standing either. Packaged foods make up 67% of the peer set, while ingredient-supply and adjacent models carry different working-capital and channel economics. The evidence points owners and boards toward business model, earnings durability and distribution quality as a more useful lens than growth or margin alone.
Key findings
- Forward multiples split sharply: 11.3x at the premium end versus 2.9x at the discount end
- Faster forecast revenue growth does not line up with the higher forward multiple
- Packaged foods hold 67% of the peer set, with distinct adjacent-model economics
- Above-median margin alone does not secure premium valuation standing
What each page shows
The analyst’s walkthrough of the deck, page by page.
- 01
CONSUMER STAPLES › FOOD, BEVERAGE AND TOBACCO › SPECIALTY AND NATURAL FOODS
The cover page introduces the Specialty and Natural Foods sector report and its valuation basis.
This report looks at how the Specialty and Natural Foods sector is priced today, using EV/EBITDA on CY2027E consensus as the primary basis. What follows separates business models, forward pricing and precedent deal terms so the picture is easy to act on.
Everything on this page
CONSUMER STAPLES › FOOD, BEVERAGE AND TOBACCO › SPECIALTY AND NATURAL FOODS Specialty and Natural Foods: Enterprise Value Multiples Sit Apart from Reported Profit Margins This report shows how business model, forward earnings and operating quality sit alongside market value across the peer set. September 2026 · Prepared by NeuraCap AI · Confidential Market data as of 2026-09-28 · primary valuation basis EV / EBITDA (CY2027E) Specialty and Natural Foods Coverage | September 2026 | Confidential | Not investment advice Sources & methodology 1
- 02CONTENTS
What This Report Covers
The contents page lists the report's five sections and appendix.
We've structured this report so the bottom line comes first: if you read only one section, section 01 carries the whole story. Everything after it builds out the evidence behind that conclusion.
Everything on this page
CONTENTS What This Report Covers 01 The Bottom Line Specialty and Natural Foods Rewards Different Models in Different Ways 02 The Landscape Shelf Proximity Does Not Create a Common Valuation Model 03 Valuation & Situations Premium Forward Pricing Sits Alongside Mixed Growth and Margins 04 Precedent Transactions Precedent Transactions Show Buyers Applying Asset-Specific Standards 05 Strategic Implications Value Strengthens When Distribution Converts into Durable Unit Economics 06 Appendix Comparables Detail, Methodology, Sources and Assumptions Specialty and Natural Foods Coverage | September 2026 | Confidential | Not investment advice Sources & methodology 2
- 0301 · THE BOTTOM LINE
Specialty and Natural Foods Spans Packaged Foods, Ingredient Supply and Adjacent Models with Distinct Pricing
This page states the report's central finding: the sector spans distinct business models with different pricing.
Among the 7 rated names, forward pricing spans from 2.9x at the discount end to 11.3x at the premium end, a gap that growth alone does not explain. Packaged foods account for 67% of the peer set, but ingredient supply and adjacent models bring different working-capital and channel economics. Margin position alone doesn't secure premium standing either, since several higher-margin names sit below the pricing benchmark and several lower-margin names sit above it. So the useful next step is matching each business to its own peer logic, not treating the sector as one model.
Everything on this page
01 · THE BOTTOM LINE Specialty and Natural Foods Spans Packaged Foods, Ingredient Supply and Adjacent Models with Distinct Pricing The full story on one page · figures on EV / EBITDA (CY2027E), market data as of 2026-09-28 Source: NeuraCap analytics platform; market data and consensus estimates as of 2026-09-28; company disclosures via SEC EDGAR where linked. Primary valuation basis: EV / EBITDA on CY2027E consensus (7 of 12 companies eligible; multiples failing the platform's plausibility gates are excluded, never plotted). Qualitative characterisations are NeuraCap views. Specialty and Natural Foods Coverage | September 2026 | Confidential | Not investment advice Sources & methodology 3 1 The Two Ends Carry Very Different Forward Prices Among the 7 names with a forward estimate, the premium end is priced at 11.3x and the discount end at 2.9x. Because the multiple is forward, the remaining gap suggests the market distinguishes the durability of forecast earnings. 2 Faster Forecast Growth Does Not Sit with the Higher Price Among the 7 names with a forward estimate, the four above the 2% growth split are priced at 5.1x, versus 6.6x for the other three. The association points owners toward earnings quality and business-model differences alongside growth. 3 Business Model Changes the Valuation Conversation Center-store better-for-you packaged foods represent 67% of the peer set. Distribution, ingredient supply and shelf-based brands bring different working-capital, route-density and gross-to-net economics. 4 Margin Alone Does Not Secure Premium Standing Among the 7 names with a forward estimate, three sit above the price benchmark despite below-benchmark margins, while three show the reverse. Velocity, trade spend and channel quality remain important context for the earnings forecast. 6.2x Sector median EV/EBITDA CY2027E consensus · 7 rated of 12 companies 11.3x Premium end EV/EBITDA vs 2.9x at the discount end top quartile (n=2) against bottom quartile (n=2) on EV/EBITDA — the spread the report explains 27 Transactions with disclosed terms 56 recorded in this tier · 2 told as case studies, the full list in the appendix
- 04SECTION 02
02
This divider introduces the market-map section on how shelf proximity does not imply a common valuation model.
Being on the same shelf doesn't mean being priced the same way. The next two pages map how business model shapes the proof points investors look for.
Everything on this page
SECTION 02 02 THE LANDSCAPE Shelf Proximity Does Not Create a Common Valuation Model Brand, supply and distribution economics call for different operating proof points. 02 of 06 Specialty and Natural Foods Coverage | September 2026 | Confidential | Not investment advice Sources & methodology 4
- 0502 · MARKET MAP
Market Value Spreads Across Three Models with Different Proof Points
This page groups the 12 approved companies into three business models and shows the median EV/EBITDA per group.
We've grouped the approved universe into three business models rather than treating the sector as one block. Median EV/EBITDA (CY2027E) differs by group, which tells us the market is already pricing these models on different terms. For an owner benchmarking value, the right comparison set starts with business model, not shelf category.
Everything on this page
02 · MARKET MAP Market Value Spreads Across Three Models with Different Proof Points 12 approved companies grouped by business segment · median EV / EBITDA (CY2027E) per group · as of 2026-09-28 Source: NeuraCap analytics platform; market data and consensus estimates as of 2026-09-28; company disclosures via SEC EDGAR where linked. Segment grouping follows the platform's classification; group medians on rated names only. "Why it matters" lines are NeuraCap views. Specialty and Natural Foods Coverage | September 2026 | Confidential | Not investment advice Sources & methodology 5 CENTER-STORE BETTER-FOR-YOU PACKAGED FOODS 8 cos median 5.8x Herbalife (HLF) The Simply Good (SMPL) John B. (JBSS) The Hain (HAIN) USANA Health (USNA) FitLife Brands (FTLF) LifeVantage (LFVN) Above Food (ABVE) Brand value depends on household penetration, repeat purchase, velocity and disciplined trade spend. SPECIALTY AND ORGANIC INGREDIENT SUPPLY 2 cos no rated names Cal-Maine Foods (CALM) Vital Farms (VITL) Certification, provenance, supply security and input-cost pass-through shape operating resilience. ADJACENT MODELS 2 cos 7.8x · 1 rated United Natural (UNFI) Medifast (MED) Distribution and direct-selling economics shift attention toward route density, working capital and reorder behavior.
- 0602 · LANDSCAPE
Packaged Foods Dominate the Set, While Adjacent Models Carry Different Economics
This page details how packaged foods dominate the approved universe while adjacent models carry different economics.
Packaged foods make up the largest share of the approved universe, but the adjacent models in this set run on different unit economics. That difference shows up in the segment medians, not just in company narratives. Knowing which model a business sits in narrows down which peers and which operating levers actually apply.
Everything on this page
02 · LANDSCAPE Packaged Foods Dominate the Set, While Adjacent Models Carry Different Economics Segment view of the approved universe · EV / EBITDA (CY2027E) medians on rated names · as of 2026-09-28 Source: NeuraCap analytics platform; market data and consensus estimates as of 2026-09-28; company disclosures via SEC EDGAR where linked. "What they do / why it matters" is a NeuraCap view. Full company-level detail in the appendix and companion tables. Specialty and Natural Foods Coverage | September 2026 | Confidential | Not investment advice Sources & methodology 6 Segment n Share of universe Median EV/EBITDA Names to know What they do — and why it matters Center-store better-for-you packaged foods 8 67% 5.8x Herbalife Nutrition Ltd. (HLF) · The Simply Good Foods Company (SMPL) · +6 more Brands need repeat velocity. This group represents 67% of the peer set. Points of distribution create value when household penetration, repeat purchase and clean gross-to-net support durable earnings. Specialty and organic ingredient supply 2 17% — Cal-Maine Foods, Inc. (CALM) · Vital Farms, Inc. (VITL) Supply quality shapes resilience. Certification, provenance and input-cost pass-through matter alongside customer concentration. Neither of the two names carries a forward estimate, limiting a direct valuation comparison. Adjacent models 2 17% 7.8x n=1 United Natural Foods, Inc. (UNFI) · Medifast, Inc. (MED) Network economics change the lens. The 7.8x figure rests on one rated name in this two-name group. The premium sits alongside a distribution model whose economics depend on route density, working capital and service levels.
- 07SECTION 03
03
This divider introduces the valuation section on premium forward pricing against mixed growth and margin profiles.
Premium forward pricing exists in this set, but it sits alongside mixed growth and margin outcomes. Only part of the peer set carries a forward estimate at all, and the two ends of that group remain far apart.
Everything on this page
SECTION 03 03 VALUATION & SITUATIONS Premium Forward Pricing Sits Alongside Mixed Growth and Margins Only part of the peer set carries an estimate, and the two ends remain far apart. 03 of 06 Specialty and Natural Foods Coverage | September 2026 | Confidential | Not investment advice Sources & methodology 7
- 0803 · PUBLIC MARKET VALUATION
The Premium End Spans Different Models and Mixed Operating Profiles
This page ranks all 7 rated companies by EV/EBITDA (CY2027E) against the 6.2x sector median.
Sorting the 7 rated names by forward multiple shows the premium tier is not one business model — it mixes different operating profiles under a similar price. The sector median sits at 6.2x, giving a fixed point to measure any name against. That mix is the reason a single sector multiple isn't a safe shortcut for any one company's value.
Everything on this page
03 · PUBLIC MARKET VALUATION The Premium End Spans Different Models and Mixed Operating Profiles EV / EBITDA (CY2027E) · all 7 rated companies, sorted descending · sector median 6.2x · as of 2026-09-28 Source: NeuraCap analytics platform; market data and consensus estimates as of 2026-09-28; company disclosures via SEC EDGAR where linked. Primary valuation basis: EV / EBITDA on CY2027E consensus (7 of 12 companies eligible; multiples failing the platform's plausibility gates are excluded, never plotted). Tier zones are NeuraCap groupings cut at the rated set's quartiles; every multiple quoted on this page is a median on the same EV / EBITDA (CY2027E) basis. Panel commentary is a NeuraCap view. Specialty and Natural Foods Coverage | September 2026 | Confidential | Not investment advice Sources & methodology 8 PREMIUM · median 11.3x CORE · median 6.2x DISCOUNT · median 2.9x Sector median 6.2x WHAT SEPARATES THE TWO ENDS Premium spans two models. The Hain Celestial Group, Inc. (HAIN) and United Natural Foods, Inc. (UNFI) sit at a forward 11.3x, pairing a packaged-food portfolio with a distribution network. Discount retains solid margins. Herbalife Nutrition Ltd. (HLF) and USANA Health Sciences, Inc. (USNA) sit at 2.9x despite margins that do not occupy the bottom of the set. Forward pricing tests durability. The forecast already credits expected growth. A gap that remains after that forecast suggests investors distinguish earnings durability, model risk and estimate confidence.
- 0903 · VALUATION DRIVERS
Profitability Separates the Two Ends: Names Above the 10% Margin Line Carry 4.7x Against 7.8x Below It
This page splits rated names into growth and margin cohorts and compares their median EV/EBITDA.
Names above the 10% margin line carry a median of 4.7x, against 7.8x for names below it — an association in the data, not a causal claim. Growth cohorts show a similar pattern: the picture is directional, not a rule to apply mechanically. For owners, this argues for looking past a single ratio and toward what's actually driving the forecast.
Everything on this page
03 · VALUATION DRIVERS Profitability Separates the Two Ends: Names Above the 10% Margin Line Carry 4.7x Against 7.8x Below It Median EV / EBITDA (CY2027E) by revenue-growth cohort and by EBITDA-margin cohort (each split at its covered median) · rated names with estimates · as of 2026-09-28 Source: NeuraCap analytics platform; market data and consensus estimates as of 2026-09-28; company disclosures via SEC EDGAR where linked. Cohort medians on rated names with the required estimates (faster n=4; slower n=3; higher-margin n=4; lower-margin n=3). Driver readings are NeuraCap views on the supplied data — association, not causation. Specialty and Natural Foods Coverage | September 2026 | Confidential | Not investment advice Sources & methodology 9 EV/EBITDA, median per cohort · growth split at 2% · EBITDA-margin split at 10% The Growth Split Runs Against a Simple Premium Story Among the 7 names with a forward estimate, the four above 2% growth are priced at 5.1x, while the other three are priced at 6.6x. The result is an observed association, not evidence that growth reduces value. Profitability and Price Do Not Sort into One Ladder Among the seven mapped names, one clears both the price and margin benchmarks, three carry higher prices with lower margins, and three show the reverse. Channel Quality Sharpens the Earnings Forecast Distribution gains matter more when velocity, repeat purchase and gross-to-net discipline show that shelf space is converting into durable demand.
- 1003 · SITUATION MAP
Growth-Led and Margin-Led Names Are Priced Differently, and Their Operating Priorities Differ Too
This page maps rated names into quadrants cut on EV/EBITDA versus the sector median and margin versus the covered median.
We've cut the rated set on two dimensions — pricing versus the sector median and margin versus the covered median — to see where names cluster. These are observations about where each name sits today, not recommendations to buy or sell. The quadrant a business sits in points to a different set of operating priorities than the one next to it.
Everything on this page
03 · SITUATION MAP Growth-Led and Margin-Led Names Are Priced Differently, and Their Operating Priorities Differ Too Cut on EV / EBITDA vs the sector median (6.2x) (rows) and EBITDA margin vs the covered median (10%) (columns) · observations, not recommendations Source: NeuraCap analytics platform; market data and consensus estimates as of 2026-09-28; company disclosures via SEC EDGAR where linked. Situation boundaries are the cohort's own medians (Directional, NeuraCap view). This page characterises situations; it does not recommend buying or selling any security. Specialty and Natural Foods Coverage | September 2026 | Confidential | Not investment advice Sources & methodology 10 Priced and Profitable Above-median multiple · above-median EBITDA margin 1 names FitLife Brands, Inc. (FTLF) One of the seven mapped names sits above both benchmarks. FitLife Brands, Inc. (FTLF) combines premium standing with an above-benchmark margin profile. Priced Ahead of Margin Above-median multiple · below-median EBITDA margin 3 names United Natural Foods, Inc. (UNFI) · The Hain Celestial Group, Inc. (HAIN) · LifeVantage Corporation (LFVN) Three of the seven mapped names sit above the price benchmark with below-benchmark margins. United Natural Foods, Inc. (UNFI), The Hain Celestial Group, Inc. (HAIN) and LifeVantage Corporation (LFVN) need durable forecasts to support that standing. Profitable Below Benchmark Below-median multiple · above-median EBITDA margin 3 names Herbalife Nutrition Ltd. (HLF) · The Simply Good Foods Company (SMPL) · USANA Health Sciences, Inc. (USNA) Three of the seven mapped names sit below the price benchmark despite above-benchmark margins. Herbalife Nutrition Ltd. (HLF), The Simply Good Foods Company (SMPL) and USANA Health Sciences, Inc. (USNA) show that current profitability alone does not secure a higher price. Below Both Benchmarks Below-median multiple · below-median EBITDA margin 0 names No rated names sit in this cell as of the analysis date.
- 1103 · THE AGENDA
The Decisions Ahead Sit Around Turning Distribution into Durable, Repeat Demand
This page frames the strategic questions this valuation pattern raises for owners and acquirers.
The pricing and margin patterns on the prior pages translate into a short list of questions any owner or acquirer should be able to answer. Chief among them: is distribution converting into repeat demand, or just into shelf count? That question is what separates durable value from a temporary placement win.
Everything on this page
03 · THE AGENDA The Decisions Ahead Sit Around Turning Distribution into Durable, Repeat Demand NeuraCap view · framed as the questions an owner or acquirer should resolve · observations, not recommendations Source: NeuraCap analytics platform; market data and consensus estimates as of 2026-09-28; company disclosures via SEC EDGAR where linked. All content on this page is Directional — NeuraCap advisory judgment grounded in the cohort data shown earlier. It does not constitute investment advice. Specialty and Natural Foods Coverage | September 2026 | Confidential | Not investment advice Sources & methodology 11 Prioritize Velocity over Shelf Count Direct resources toward retailers, formats and items where points of distribution convert into repeat purchase and better unit economics. What changes the answer: Sustained velocity and household repeat after the shelf reset. Tighten Revenue Quality and Mix Refine pricing, promotion and channel mix where trade spend or slotting fees dilute the benefit of distribution growth. What changes the answer: A cleaner gross-to-net bridge without weaker volume quality. Build Resilience into Supply Balance co-manufacturing flexibility, qualified redundancy and input-cost pass-through against the cost of owned capacity. What changes the answer: More stable service levels and margins through input and freight volatility. Choose the Relevant Value Benchmark The observed forward range from 1.9x to 14.9x shows how wide peer pricing can be. Business model, earnings durability and estimate confidence narrow the useful reference set. What changes the answer: A peer group that matches the company’s revenue model, channel exposure and cost structure.
- 12SECTION 04
04
This divider introduces the precedent transactions section on asset-specific deal benchmarks.
Buyers in this sector haven't applied one benchmark across the board. The next page walks through how brand, nutrition and corporate assets have attracted different disclosed terms.
Everything on this page
SECTION 04 04 PRECEDENT TRANSACTIONS Precedent Transactions Show Buyers Applying Asset-Specific Standards Brand, nutrition and corporate assets have attracted widely different disclosed terms. 04 of 06 Specialty and Natural Foods Coverage | September 2026 | Confidential | Not investment advice Sources & methodology 12
- 1304 · DEAL CASE STUDIES
Precedent Transactions Apply Different Benchmarks to Different Assets
This page walks through two precedent transactions as case studies of asset-specific deal benchmarks.
Of the transactions with disclosed terms, we've picked two to walk through in depth because they show how differently the market has valued different kinds of assets. These multiples are LTM at announcement, so they sit on a different basis than the CY2027E figures earlier in this report — we're not claiming a spread between them. The takeaway is that deal benchmarks follow the asset, not a single sector rule.
Everything on this page
04 · DEAL CASE STUDIES Precedent Transactions Apply Different Benchmarks to Different Assets 2 of 27 transactions with disclosed terms, told as case studies · multiples on LTM financials at announcement where disclosed · the complete list is in the appendix · as of 2026-09-28 Source: NeuraCap analytics platform; market data and consensus estimates as of 2026-09-28; company disclosures via SEC EDGAR where linked. 72 precedent record(s) carry data-quality flags (deal value unit unresolved; divestiture roles reassigned; duplicate precedent id); figures are shown as recorded in the filing. 29 recorded transactions with neither a disclosed value nor a multiple are omitted from the precedent list and the case studies (kept in the companion workbook). Deal multiples are LTM at announcement (Definitive, from filings); they are not directly comparable to the CY2027E public basis and no spread is claimed. "Why the deal happened" is a NeuraCap read of the recorded evidence. Specialty and Natural Foods Coverage | September 2026 | Confidential | Not investment advice Sources & methodology 13 Sep-2026 $323M AURELIUS AURELIUS agreed to acquire International Business for $323M. EV / LTM revenue n/a EV / LTM EBITDA n/a WHY THE DEAL HAPPENED The transaction suggests AURELIUS saw a strategic fit with International Business. The pairing also shows buyer interest extending beyond named branded-food assets. HOW THE TARGET WAS VALUED The disclosed value was $323M. It provides a whole-company value reference without a disclosed revenue or EBITDA multiple. Sep-2019 $24M Celsius Holdings, Inc. Celsius Holdings, Inc. acquired Func Food Group Oyj for $24M. EV / LTM revenue n/a EV / LTM EBITDA n/a WHY THE DEAL HAPPENED The pairing suggests adjacency between Celsius Holdings, Inc. and Func Food Group Oyj. It adds a strategic-buyer reference to the transaction record. HOW THE TARGET WAS VALUED The disclosed value was $24M. It provides a whole-company value reference without a disclosed revenue or EBITDA multiple.
- 14SECTION 05
05
This divider introduces the strategic implications section on distribution converting into durable unit economics.
Value in this sector strengthens where distribution turns into durable unit economics — velocity, revenue quality and cost resilience. The next page sets out what that means across the different business models covered here.
Everything on this page
SECTION 05 05 STRATEGIC IMPLICATIONS Value Strengthens When Distribution Converts into Durable Unit Economics Velocity, revenue quality and cost resilience sharpen the case across business models. 05 of 06 Specialty and Natural Foods Coverage | September 2026 | Confidential | Not investment advice Sources & methodology 14
- 1505 · STRATEGIC IMPLICATIONS
Distribution That Turns into Repeat Demand Is Where Value Builds, Ahead of Added Complexity
This page sets out the strategic implications for owners, management teams and boards over the next twelve months.
Distribution that converts into repeat demand is where value builds in this sector, ahead of the complexity that comes with scaling further. That puts velocity, revenue quality and supply resilience ahead of shelf count alone as the operating priorities to watch. These are NeuraCap's directional views drawn from the analysis in this report, not a recommendation on any security. For owners and boards, the near-term question is whether current growth is repeat-purchase growth or promotion-led growth.
Everything on this page
05 · STRATEGIC IMPLICATIONS Distribution That Turns into Repeat Demand Is Where Value Builds, Ahead of Added Complexity NeuraCap view · the questions this data puts on the table for the next twelve months Source: NeuraCap analytics platform; market data and consensus estimates as of 2026-09-28; company disclosures via SEC EDGAR where linked. This page is Directional — NeuraCap views drawn from the analysis in this report. Observations, not recommendations. Specialty and Natural Foods Coverage | September 2026 | Confidential | Not investment advice Sources & methodology 15 FOR OWNERS Protect the Quality of Growth Favor distribution gains supported by velocity, repeat purchase and pricing discipline. Shelf space that depends on promotional depth can weaken revenue quality. FOR MANAGEMENT TEAMS Make Margin Durability Operational Focus on mix, trade spend, co-manufacturing resilience and input-cost pass-through. These levers clarify whether forecast earnings can hold through a cycle. FOR BOARDS Match Capital to the Model Test build-versus-buy choices against channel economics, working-capital needs and the company’s ability to absorb added complexity.
- 16SECTION 06
06
This divider introduces the appendix covering the full comparables universe, methodology and sources.
The next pages carry the full comparables universe, the valuation methodology and where each underlying disclosure sits, for anyone who wants to trace a figure back to its source.
Everything on this page
SECTION 06 06 APPENDIX The Full Universe, Methodology and Sources Comparables detail behind every figure in the body, the valuation basis, and where each underlying disclosure lives. 06 of 06 Specialty and Natural Foods Coverage | September 2026 | Confidential | Not investment advice Sources & methodology 16
- 1706 · PUBLIC COMPARABLES (1 OF 1)
Public Comparables on EV / EBITDA (CY2027E), Grouped by Valuation Tier
This appendix page lists public comparables on EV/EBITDA (CY2027E), grouped by valuation tier.
This page carries all 7 rated companies plus the 5 names without an eligible multiple, shaded against the 6.2x sector median. It's the reference table behind every valuation chart earlier in the report. Use it to check any single-company figure against its tier before applying a benchmark.
Everything on this page
06 · PUBLIC COMPARABLES (1 OF 1) Public Comparables on EV / EBITDA (CY2027E), Grouped by Valuation Tier Teal shading marks a EV/EBITDA above the sector median (6.2x); amber marks below · 7 rated companies; 5 not rated (no eligible EV/EBITDA) · tickers link to the underlying source · as of 2026-09-28 Source: NeuraCap analytics platform; market data and consensus estimates as of 2026-09-28; company disclosures via SEC EDGAR where linked. All 7 rated rows are in this appendix and in the companion workbook, which carries the complete field set. Names without an eligible multiple are listed in the companion workbook. Specialty and Natural Foods Coverage | September 2026 | Confidential | Not investment advice Sources & methodology 17 Company Ticker Segment EV EV/EBITDA (CY2027E) Rev growth EBITDA margin Rule of 40 PREMIUM — ≥7.2x · median 11.3x · 2 companies The Hain Celestial Group, Inc. HAIN Center-store better-for-you packaged foods $596M 14.9x -5% 8% -1 United Natural Foods, Inc. UNFI Natural and organic food distribution $5.9B 7.8x 2% 2% 5 CORE — 4.7x–7.2x · median 6.2x · 3 companies LifeVantage Corporation LFVN Center-store better-for-you packaged foods $76M 6.6x 0% 6% 6 FitLife Brands, Inc. FTLF Center-store better-for-you packaged foods $128M 6.2x 6% 15% 25 The Simply Good Foods Company SMPL Center-store better-for-you packaged foods $1.2B 5.4x -2% 17% 15 DISCOUNT — <4.7x · median 2.9x · 2 companies Herbalife Nutrition Ltd. HLF Center-store better-for-you packaged foods $3.0B 4.0x 3% 13% 17 USANA Health Sciences, Inc. USNA Center-store better-for-you packaged foods $176M 1.9x 4% 10% 14
- 1806 · PRECEDENT TRANSACTIONS (1 OF 2)
All Precedent Transactions with Disclosed Terms, Newest First
This appendix page lists precedent transactions with disclosed terms, newest first.
This page begins the full list of transactions with disclosed terms, ordered newest first, with multiples on LTM financials at announcement where disclosed. It's the detail behind the case studies shown earlier in the report.
Everything on this page
06 · PRECEDENT TRANSACTIONS (1 OF 2) All Precedent Transactions with Disclosed Terms, Newest First 27 transactions with disclosed terms in this tier (56 recorded) · multiples on LTM financials at announcement where disclosed · deal values link to the underlying filing · as of 2026-09-28 Source: NeuraCap analytics platform; market data and consensus estimates as of 2026-09-28; company disclosures via SEC EDGAR where linked. 72 precedent record(s) carry data-quality flags (deal value unit unresolved; divestiture roles reassigned; duplicate precedent id); figures are shown as recorded in the filing. 29 recorded transactions with neither a disclosed value nor a multiple are omitted from the precedent list and the case studies (kept in the companion workbook). Deal multiples are LTM at announcement (Definitive, from filings); they are not directly comparable to the CY2027E public basis and no spread is claimed. 18 of 27 transactions shown; the rest are in the companion workbook. Specialty and Natural Foods Coverage | September 2026 | Confidential | Not investment advice Sources & methodology 18 Date Transaction EV EV/LTM Rev EV/LTM EBITDA Why it matters Sep-2026 AURELIUS → International Business $323M n/a n/a The transaction involving International Business broadens the observed buyer mix and provides a disclosed whole-company value reference. Nov-2025 n/a → The Clorox Company n/a n/a 12.3x The announced transaction involving The Clorox Company was recorded at 12.3x EV / EBITDA, showing a premium earnings benchmark in the transaction record. Apr-2024 NA → PT Industri Jamu dan Farmasi Sido Muncul Tbk n/a 5.7x n/a PT Industri Jamu dan Farmasi Sido Muncul Tbk was recorded at 5.7x EV / Revenue, illustrating how revenue can become the practical benchmark when that is the disclosed measure. Jul-2023 Mars, Incorporated → Kevin’s Natural Foods n/a n/a 0.7x The terminated transaction between Mars, Incorporated and Kevin’s Natural Foods was recorded at 0.7x EV / EBITDA. Its status limits how directly it should anchor current expectations. Apr-2023 Kirin Holdings Company, Limited → Blackmores Limited n/a n/a 23.1x Kirin Holdings Company, Limited and Blackmores Limited were linked in an announced transaction recorded at 23.1x EV / EBITDA. Aug-2020 Hometown Food Company → Birch Benders, LLC n/a n/a 14.8x Hometown Food Company completed its acquisition of Birch Benders, LLC at a recorded 14.8x EV / EBITDA. Sep-2019 Celsius Holdings, Inc. → Func Food Group Oyj $24M n/a n/a Celsius Holdings, Inc. completed its acquisition of Func Food Group Oyj, adding another strategic pairing to the transaction record. Aug-2019 Simply Good Foods Company → Quest Nutrition, LLC n/a n/a 20.0x Simply Good Foods Company announced its acquisition of Quest Nutrition, LLC at a recorded 20.0x EV / EBITDA. Nov-2018 Science in Sport plc → PhD Nutrition Ltd n/a n/a 11.4x Science in Sport plc announced its acquisition of PhD Nutrition Ltd at a recorded 11.4x EV / EBITDA.
- 1906 · PRECEDENT TRANSACTIONS (2 OF 2)
All Precedent Transactions with Disclosed Terms, Newest First
This appendix page continues the list of precedent transactions with disclosed terms, newest first.
This page completes the list of disclosed-term transactions carried into this appendix. Together with the prior page, it gives the full evidence base behind the precedent case studies discussed earlier.
Everything on this page
06 · PRECEDENT TRANSACTIONS (2 OF 2) All Precedent Transactions with Disclosed Terms, Newest First 27 transactions with disclosed terms in this tier (56 recorded) · multiples on LTM financials at announcement where disclosed · deal values link to the underlying filing · as of 2026-09-28 Source: NeuraCap analytics platform; market data and consensus estimates as of 2026-09-28; company disclosures via SEC EDGAR where linked. 72 precedent record(s) carry data-quality flags (deal value unit unresolved; divestiture roles reassigned; duplicate precedent id); figures are shown as recorded in the filing. 29 recorded transactions with neither a disclosed value nor a multiple are omitted from the precedent list and the case studies (kept in the companion workbook). Deal multiples are LTM at announcement (Definitive, from filings); they are not directly comparable to the CY2027E public basis and no spread is claimed. 18 of 27 transactions shown; the rest are in the companion workbook. Specialty and Natural Foods Coverage | September 2026 | Confidential | Not investment advice Sources & methodology 19 Date Transaction EV EV/LTM Rev EV/LTM EBITDA Why it matters Oct-2018 Glanbia plc → Slimfast n/a n/a 14.6x Dec-2017 Nestlé S.A. → Atrium Innovations Inc. n/a n/a 14.0x Aug-2017 B&G Foods → Back to Nature Foods Company, LLC n/a n/a 9.6x Value shown as recorded in the filing; deal value unit unresolved. May-2017 HGGC, LLC → Nutraceutical International Corporation n/a n/a 9.2x Apr-2017 Groupe Danone → WhiteWave Foods n/a n/a 23.4x Value shown as recorded in the filing; deal value unit unresolved. Feb-2017 Reckitt Benckiser Group plc → Mead Johnson Nutrition Company n/a 17.7x 17.4x Jul-2016 Danone S.A. → The WhiteWave Foods Company n/a 24.7x 25.0x Nov-2015 Pinnacle Foods Inc. → Boulder Brands, Inc. n/a 15.7x 14.7x Sep-2015 Biostime Healthy Australia Pty Ltd. → Swisse Wellness Pty Ltd. n/a n/a 10.2x
- 2006 · METHODOLOGY
Sources, Assumptions and Data Quality
This page sets out the sources, valuation assumptions and data-quality notes behind the report.
This page sets out how the comparables and precedent sets were assembled, what was excluded and on what basis, and how the valuation methodology was applied throughout the report. It's the reference point for anyone who wants to understand how a specific figure was derived. Treating this page as the starting point makes the rest of the report easier to check and easier to trust.
Everything on this page
06 · METHODOLOGY Sources, Assumptions and Data Quality How this report was built, what was excluded, and where every underlying disclosure lives · as of 2026-09-28 Every figure in this report links to the record it was taken from. Where a figure has no link, the appendix names its source and the basis on which it was read. Specialty and Natural Foods Coverage | September 2026 | Confidential | Not investment advice 20 VALUATION BASIS Primary valuation basis: EV / EBITDA on CY2027E consensus (7 of 12 companies eligible; multiples failing the platform's plausibility gates are excluded, never plotted). EV / EBITDA on CY2027E is the lead convention: it is the sector-appropriate prior for Specialty and Natural Foods and it clears the coverage gate with 7 of 12 companies (58%). EV / Revenue, P / E are carried as a cross-check. The set earns: 7 of the 8 companies with a reported forward EBITDA carry a meaningful one, so the profit multiple leads and a revenue multiple would understate what the market is pricing. DATA QUALITY & EXCLUSIONS 12 records were excluded or quarantined by the platform's validation gates (unit errors, implausible ratios, ineligible securities and classification failures); the full ledger ships in the companion tables and never feeds a statistic in this report. DEFINITIVE VS DIRECTIONAL Definitive content is disclosed or consensus data passed through stated arithmetic. Directional content — tier boundaries, situation cuts, "why it matters" commentary, the agenda pages — is NeuraCap analyst judgment and is labeled as such where it appears. WHAT THIS REPORT IS NOT This report characterises a sector. It does not recommend buying, selling or holding any security, and no statement in it should be read as investment advice or a price target. WHERE THE DATA LIVES 594 registered source documents stand behind the figures in this report. Metric hyperlinks throughout the deck open the specific filing or data record; by publisher: sec.gov (593) · home.treasury.gov (1). The companion workbook beside this deck carries the complete source index.
- 21
Higher Forward Prices Sit Alongside Distinct Models and Mixed Margins in This Sample.
The closing page restates that higher forward prices sit alongside distinct business models and mixed margins in this sample.
Higher forward prices sit alongside distinct business models and mixed margins across this peer set — pricing here doesn't follow a single rule. That's the reason to anchor any valuation conversation in business model and earnings durability rather than the sector average alone.
Everything on this page
Higher Forward Prices Sit Alongside Distinct Models and Mixed Margins in This Sample. NeuraCap AI — Specialty and Natural Foods Coverage September 2026 · Prepared by NeuraCap AI · Confidential Specialty and Natural Foods Coverage | September 2026 | Confidential | Not investment advice Sources & methodology 21
Sources and methodology
This report covers Specialty and Natural Foods (Consumer Staples › Food, Beverage and Tobacco › Specialty and Natural Foods) with market data and consensus estimates as of September 28, 2026. The company universe is the 12 listed companies whose core business is Specialty and Natural Foods according to NeuraCap's industry classification of each company's reported business segments (a company is included only when this industry is central to what it does, not merely adjacent to it). Companies in the set: Above Food Ingredients Inc. Common Stock (ABVE), Cal-Maine Foods, Inc. (CALM), FitLife Brands, Inc. (FTLF), The Hain Celestial Group, Inc. (HAIN), Herbalife Nutrition Ltd. (HLF), John B. Sanfilippo & Son, Inc. (JBSS), LifeVantage Corporation (LFVN), Medifast, Inc. (MED), The Simply Good Foods Company (SMPL), United Natural Foods, Inc. (UNFI), USANA Health Sciences, Inc. (USNA), Vital Farms, Inc. (VITL). The market map groups them by business vertical — Center-store better-for-you packaged foods: 8 companies (HLF, SMPL, JBSS, HAIN, USNA, FTLF, LFVN, ABVE); Specialty and organic ingredient supply: 2 companies (CALM, VITL); Adjacent models: 2 companies (UNFI, MED). 7 of the 12 companies carry a valid multiple on the primary valuation basis and form the rated set behind every cohort statistic; the others are shown but do not enter the statistics.
Scope and company universe
This report covers Specialty and Natural Foods (Consumer Staples › Food, Beverage and Tobacco › Specialty and Natural Foods) with market data and consensus estimates as of September 28, 2026. The company universe is the 12 listed companies whose core business is Specialty and Natural Foods according to NeuraCap's industry classification of each company's reported business segments (a company is included only when this industry is central to what it does, not merely adjacent to it). Companies in the set: Above Food Ingredients Inc. Common Stock (ABVE), Cal-Maine Foods, Inc. (CALM), FitLife Brands, Inc. (FTLF), The Hain Celestial Group, Inc. (HAIN), Herbalife Nutrition Ltd. (HLF), John B. Sanfilippo & Son, Inc. (JBSS), LifeVantage Corporation (LFVN), Medifast, Inc. (MED), The Simply Good Foods Company (SMPL), United Natural Foods, Inc. (UNFI), USANA Health Sciences, Inc. (USNA), Vital Farms, Inc. (VITL). The market map groups them by business vertical — Center-store better-for-you packaged foods: 8 companies (HLF, SMPL, JBSS, HAIN, USNA, FTLF, LFVN, ABVE); Specialty and organic ingredient supply: 2 companies (CALM, VITL); Adjacent models: 2 companies (UNFI, MED). 7 of the 12 companies carry a valid multiple on the primary valuation basis and form the rated set behind every cohort statistic; the others are shown but do not enter the statistics.
What was excluded and why
12 records failed a validation gate and never feed a statistic in this report (12 excluded from aggregate). Each exclusion, with its reason: FTLF — EBITDA 14006.0000 is below the $1000000 materiality floor; any multiple would be meaningless (effect: excluded from aggregate) · HAIN — Non-positive EPS; P/E is n/m (effect: excluded from aggregate) · HAIN — Non-positive EPS; P/E is n/m (effect: excluded from aggregate) · MED — EBITDA is non-positive; EV/EBITDA is n/m (effect: excluded from aggregate) · MED — EBITDA is non-positive; EV/EBITDA is n/m (effect: excluded from aggregate) · MED — EBITDA 544000.0000 is below the $1000000 materiality floor; any multiple would be meaningless (effect: excluded from aggregate) · MED — Non-positive EPS; P/E is n/m (effect: excluded from aggregate) · MED — Non-positive EPS; P/E is n/m (effect: excluded from aggregate) · MED — Non-positive EPS; P/E is n/m (effect: excluded from aggregate) · MED — Non-positive EPS; P/E is n/m (effect: excluded from aggregate) · UNFI — Non-positive EPS; P/E is n/m (effect: excluded from aggregate) · VITL — Non-positive EPS; P/E is n/m (effect: excluded from aggregate)
Primary valuation basis and how it was chosen
Primary valuation basis: EV / EBITDA on CY2027E consensus (7 of 12 companies eligible; multiples failing the platform's plausibility gates are excluded, never plotted). EV / EBITDA on CY2027E is the lead convention: it is the sector-appropriate prior for Specialty and Natural Foods and it clears the coverage gate with 7 of 12 companies (58%). EV / Revenue, P / E are carried as a cross-check. The set earns: 7 of the 8 companies with a reported forward EBITDA carry a meaningful one, so the profit multiple leads and a revenue multiple would understate what the market is pricing. The basis is selected in two steps: the industry's customary valuation conventions set the order of preference, and each convention is then tested for coverage — the share of companies with a valid, plausibility-checked multiple on the chosen period. A convention is used only when enough companies carry it; the best-covered convention is used, and disclosed, when none clears the threshold. Coverage measured for this report — EV / EBITDA: 7 of 12 companies; EV / rEVenue: 10 of 12 companies; P/E: 9 of 12 companies. 1 company shows a non-meaningful EV / EBITDA denominator and is excluded from that statistic. 1 company shows a non-meaningful P / E denominator and is excluded from that statistic.
How the multiples and statistics are computed
Enterprise value (EV) is market capitalisation at the as-of date plus total debt minus cash and equivalents from the latest reported balance sheet, reconciled against the platform's stored value and disclosed where the two differ. Forward multiples divide EV (or the share price for P/E) by the consensus estimate for the stated calendar period; trailing multiples use the last twelve months of reported figures from SEC filings. A multiple with a negative or immaterial denominator is treated as not meaningful and excluded from every statistic. Cohort statistics are medians and quartiles over the rated set only; a group median with fewer than three observations is shown as the single company's figure and labelled as such. Valuation tiers cut the rated set at its quartiles (tiers cut at the rated set's quartiles: Premium ≥7.2x, Core 4.7x–7.2x, Discount <4.7x — NeuraCap groupings). Revenue growth compares consecutive calendar-year consensus revenue; EBITDA margin divides consensus EBITDA by consensus revenue for the same period. Figures shown in this report and the calculation behind each: 6.2x = median(ev_ebitda CY2027E) (7 rated companies) · 11.3x = median(ev_ebitda CY2027E) within Premium tier (n=2) · 6.2x = median(ev_ebitda CY2027E) within Core tier (n=3) · 2.9x = median(ev_ebitda CY2027E) within Discount tier (n=2) · 5.1x = median(ev_ebitda CY2027E) | growth ≥ 2% (n=4) · 6.6x = median(ev_ebitda CY2027E) | growth < 2% (n=3) · 4.7x = median(ev_ebitda CY2027E) | EBITDA margin ≥ 10% (n=4) · 7.8x = median(ev_ebitda CY2027E) | EBITDA margin < 10% (n=3) · 14% = median Rule of 40 score (revenue growth + EBITDA margin) (n=7)
Precedent transactions: what is in the record and why
The precedent record holds the M&A transactions in Specialty and Natural Foods recorded from SEC filings (8-K announcements and the documents they reference), newest first, with each value and multiple linked to the exact passage in the filing that states it. 56 transactions were recorded for this industry; 27 are shown. 29 recorded transactions with neither a disclosed value nor a multiple are omitted because they say nothing about price; they remain in the companion workbook. Deal multiples are enterprise value over the target's last-twelve-month revenue or EBITDA at announcement, as disclosed; they are not restated to the public basis and no spread to the public multiples is claimed. Before a transaction reaches the record it passes a screen for mirrored or duplicate filings of the same deal, for divestitures where the filer is the seller rather than the buyer, for carve-outs recorded under the parent's name, and for values whose citation describes something other than the price paid (a debt raise, a termination fee); such records are corrected or excluded and the correction is noted. Data-quality notes on this record: 19 × deal value unit unresolved; 48 × no evidence record; 4 × duplicate precedent id; 1 × divestiture roles reassigned. Case studies lead with the 2 richest stories — disclosed value, a readable multiple, newest first.
Sources
Company financials and transaction terms come from the companies' own SEC filings on EDGAR (10-K, 10-Q and 8-K documents), linked from each figure in the report. Forward figures are analyst consensus estimates for the calendar periods shown. Share prices and market capitalisations are market data as of September 28, 2026. Treasury yields are published by the U.S. Department of the Treasury. 598 source documents stand behind this report; by publisher domain: sec.gov, home.treasury.gov (1). Every figure on every page is traceable to one of these records; nothing in the report is derived from outside data.
Interpretation and important notice
Tier labels, situation maps, the agenda and the implications pages are NeuraCap analytical views drawn from the recorded evidence and are labelled as such. The report is informational: it is not investment advice, not a recommendation to buy or sell any security, not an opinion of value and not an offer of any kind. Readers should perform their own diligence before acting on anything described here.
Sources linked in the report
- Herbalife (HLF) (sec.gov)
- The Simply Good (SMPL) (sec.gov)
- John B. (JBSS) (sec.gov)
- The Hain (HAIN) (sec.gov)
- USANA Health (USNA) (sec.gov)
- FitLife Brands (FTLF) (sec.gov)
- LifeVantage (LFVN) (sec.gov)
- Vital Farms (VITL) (sec.gov)
- United Natural (UNFI) (sec.gov)
- $323M (sec.gov)
- $24M (sec.gov)
- n/a (sec.gov)
- n/a (sec.gov)
- n/a (sec.gov)
- n/a (sec.gov)
- n/a (sec.gov)
- 14.8x (sec.gov)
- n/a (sec.gov)
- n/a (sec.gov)
- n/a (sec.gov)
- n/a (sec.gov)
- 17.7x (sec.gov)
- n/a (sec.gov)
- sec.gov (593) (sec.gov)
- home.treasury.gov (1) (home.treasury.gov)
This report is published for information only. It is not a recommendation to buy or sell any security, an offer or solicitation, an appraisal or a fairness opinion, and no fiduciary relationship is created by reading it. Multiples that fail NeuraCap’s plausibility gates are excluded and never plotted. See the full methodology and the disclaimer.
More coverage in Consumer Staples
- M&A Update · 29 September 2026Agricultural Products and Commodities M&A update, 14–28 September 2026
- Sector Outlook · 29 September 2026Agricultural Products and Commodities Sector Outlook — September 2026
- M&A Update · 29 September 2026Brewers M&A update, 14–28 September 2026
- Sector Outlook · 29 September 2026Brewers Sector Outlook — September 2026
Want this analysis for a company in Specialty and Natural Foods?
Company valuation reports run the same method against a single business — public or private.
